Seasonal affective disorder.

Area of Science:

• Psychiatry
• Chronobiology
• Mood Disorders

Background:

• Seasonal affective disorder (SAD) is characterized by mood disturbances with a distinct seasonal pattern.
• Symptoms typically emerge in autumn/winter and remit in spring/summer, impacting approximately 5% of the U.S. population annually.
• Despite its seasonal nature, SAD can cause significant functional impairment due to depressive symptoms.

Purpose of the Study:

• To review the treatment options for seasonal affective disorder.
• To highlight the efficacy and patient-centered approach in managing SAD.
• To provide guidance on the prophylactic use of treatments to prevent symptom recurrence.

Main Methods:

• Review of current therapeutic interventions for SAD, including light therapy, pharmacotherapy, and cognitive behavior therapy.
• Assessment of treatment efficacy and tolerability.
• Emphasis on patient preference in selecting first-line management strategies.

Main Results:

• Light therapy is a well-tolerated treatment, with clinical improvement often observed within 1-2 weeks.
• Pharmacotherapy with antidepressants and cognitive behavior therapy are equally effective as light therapy.
• Continuous light therapy through winter is recommended to prevent relapse until natural symptom remission.

Conclusions:

• Multiple effective treatment options exist for seasonal affective disorder, including light therapy, antidepressants, and CBT.
• Treatment choice should prioritize patient preference due to comparable efficacy across modalities.
• Prophylactic treatment before the onset of the typical SAD season can help prevent symptom recurrence.